Is there anything like European Warning Letters?

Recommendation
Tuesday, 13 May 2025 9 .00 - 16.15 h
European Warning Letters? Is there such a thing? Basically, no. Warning Letters are issued by the US-American FDA. However, there is something "comparable" namely the "Non-Compliance Reports" published in the EudraGMDP database. These reports are generated by the competent authorities, which conduct GMP inspections at the premises and upload their reports into the database. Now, one may question what the authorities has complained about in the last three months.
In this period, several Non-Compliance Reports were published for both European and non-European manufacturers. The European companies in question are located in the Czech Republic, Denmark, Italy and the Netherlands. The non-European locations with deficiencies were located in India (two companies) and China.
The GMP deficiencies are classified as "critical", "major" and "other", whereby only "critical" and "major" findings are usually listed in the reports. The following deficiencies were found, among others:
- Mould in production rooms
- No Deviation System and Change Control System
- Cross-contamination issues
- Reworking (API)
- Deficiencies in aseptic manufacture
- Lack of management review
- No trend analysis
- No/or inadequate self-inspections
- Missing CAPA system
- Deviations from the CEP
The difference to FDA Warning Letters is that Non-Compliance Reports are final decisions about a GMP non-compliance. Warning Letters are a warning - allowing companies to react. You can find the complete list of Non-Compliance Reports in the EudraGMDP database. Please also see the latest GMP Non-Compliance Reports.
Related GMP News
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years